NCT05907993View on ClinicalTrials.gov

Ibuprofen Versus Ketorolac For Postoperative Pain Relief After Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 30, 2023

Conditions
Pain, Postoperative
Interventions
DRUG

Ibuprofen 800 mg

Intravenous Ibuprofen versus intravenous Ketorolac for postoperative pain relief

Trial Locations (1)

21431

Ahmed S. Shehab, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER